HI SB798

Requires a chronic pain medication agreement to be executed between a patient and any prescriber of narcotic drugs when the patient is prescribed such medication for chronic pain lasting three months or longer.

Directs the narcotics enforcement division administrator to develop and make available a template chronic pain medication agreement that includes informed consent, consent to random pill counts, warnings about morphine equianalgesic dose limits (120mg daily) and acetaminophen limits (3 grams daily), and a recommendation to use a single pharmacy or electronically-linked pharmacy network.

Includes a statement in the template informing patients that violations of controlled substance procurement laws constitute a class C felony.

Exempts emergency room, urgent care, hospice, palliative care, and terminally ill patients and their providers from the agreement requirements.

Defines "narcotic drug" as schedule II and III controlled substances including hydrocodone, oxycodone, morphine, codeine, hydromorphone, benzodiazepines, and carisoprodol; effective July 1, 2050 for all agreements entered into on or after September 1, 2015.